Skip to main content
Premium Trial:

Request an Annual Quote

Lion s Q4 Revenues Slide; Sale of Bioinformatics Biz Expected by End of Summer

NEW YORK, July 29 (GenomeWeb News) - Lion Bioscience posted a nearly 70-percent decline in quarterly revenues for its fourth fiscal quarter ended March 31, 2005, according to full-year results that the company released today.  

 

According to these results, receipts fell to around €1.2 million ($1.46 million) for the quarter, from €3.9 million in the year-ago period.

 

The company reported €10 million in total revenues for its 2004/2005 fiscal year, a decline of nearly 50 percent from €19.7 million in the prior fiscal year, but in line with projected revenues of €8 million to €10 million for the current year.  

 

Due to the planned sale of its UK-based bioinformatics business, Lion reclassified all revenues and expenses related to this business as discontinued operations, with the prior-year figures adjusted accordingly, the company said.

 

In line with this reclassification, Lion reported adjusted total revenues of €200,000 for the 12 months ending March 31 compared with €300,000 in adjusted revenues for the prior fiscal year. These figures include only those revenues based on income from Lion's Cambridge, Mass., subsidiary.  

 

Lion said in a statement that "the sales process of the bioinformatics business started successfully" and that it expects to close a sale "before the summer break."

 

Lion said it narrowed its net loss for the year to €13.2 million from €20.8 million in the prior fiscal year.

 

The company had previously projected €10 million to €11 million in net losses for the year ended March 31.

 

Lion said that it held cash and cash equivalents, including marketable securities, of €25.6 million as of March 31.

 

Lion also postponed the announcement of its financial results for the period ending June 30 from Aug. 4 to Aug. 12.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.